tetano
Editor, Senior Moderator
Microbes Infect. 2017 Sep 10. pii: S1286-4579(17)30141-7. doi: 10.1016/j.micinf.2017.08.010. [Epub ahead of print]
[h=1]Highly conserved M2e and hemagglutinin epitope-based recombinant proteins induce protection against influenza virus infection.[/h] Guo Y[SUP]1[/SUP], He L[SUP]2[/SUP], Song N[SUP]1[/SUP], Li P[SUP]1[/SUP], Sun S[SUP]1[/SUP], Zhao G[SUP]1[/SUP], Tai W[SUP]3[/SUP], Jiang S[SUP]4[/SUP], Du L[SUP]5[/SUP], Zhou Y[SUP]6[/SUP].
[h=3]Author information[/h]
[h=3]Abstract[/h] Highly pathogenic influenza viruses continue to cause serious threat to public health due to their pandemic potential, calling for an urgent need to develop effective, safe, convenient, and universal vaccines against influenza virus infection. In this study, we constructed two recombinant protein vaccines, 2H5M2e-2H7M2e-H5FP-H7FP (hereinafter M2e-FP-1) and 2H5M2e-H5FP-2H7M2e-H7FP (hereinafter M2e-FP-2), by respectively linking highly conserved sequences of two molecules of ectodomain of M2 (M2e) and one molecule of fusion peptide (FP) epitope of hemagglutinin (HA) of H5N1 and H7N9 influenza viruses in different orders. The E.coli-expressed M2e-FP-1 and M2e-FP-2 proteins induced similarly high-titer M2e-FP-specific antibodies in the immunized mice. Importantly, both proteins were able to prevent lethal challenge of heterologous H1N1 influenza virus, with significantly reduced viral titers and alleviated pathological changes in the lungs, as well as increased body weight and complete survivals, in the challenge mice. Taken together, our study demonstrates that highly conserved M2e and FP epitope of HA of H5N1 and H7N9 influenza viruses can be used as important targets for development of safe and economical universal influenza vaccines, and that the position of H7N9 M2e and H5N1 HA epitope sequences in the vaccine components had no significant effects on the immunogenicity and efficacy of M2e-FP-based subunit vaccines.
Copyright ? 2017 Institut Pasteur. Published by Elsevier Masson SAS. All rights reserved.
[h=4]KEYWORDS:[/h] Influenza virus; M2e; hemagglutinin fusion peptide; protection; universal vaccines
PMID: 28903071 DOI: 10.1016/j.micinf.2017.08.010
[h=1]Highly conserved M2e and hemagglutinin epitope-based recombinant proteins induce protection against influenza virus infection.[/h] Guo Y[SUP]1[/SUP], He L[SUP]2[/SUP], Song N[SUP]1[/SUP], Li P[SUP]1[/SUP], Sun S[SUP]1[/SUP], Zhao G[SUP]1[/SUP], Tai W[SUP]3[/SUP], Jiang S[SUP]4[/SUP], Du L[SUP]5[/SUP], Zhou Y[SUP]6[/SUP].
[h=3]Author information[/h]
[h=3]Abstract[/h] Highly pathogenic influenza viruses continue to cause serious threat to public health due to their pandemic potential, calling for an urgent need to develop effective, safe, convenient, and universal vaccines against influenza virus infection. In this study, we constructed two recombinant protein vaccines, 2H5M2e-2H7M2e-H5FP-H7FP (hereinafter M2e-FP-1) and 2H5M2e-H5FP-2H7M2e-H7FP (hereinafter M2e-FP-2), by respectively linking highly conserved sequences of two molecules of ectodomain of M2 (M2e) and one molecule of fusion peptide (FP) epitope of hemagglutinin (HA) of H5N1 and H7N9 influenza viruses in different orders. The E.coli-expressed M2e-FP-1 and M2e-FP-2 proteins induced similarly high-titer M2e-FP-specific antibodies in the immunized mice. Importantly, both proteins were able to prevent lethal challenge of heterologous H1N1 influenza virus, with significantly reduced viral titers and alleviated pathological changes in the lungs, as well as increased body weight and complete survivals, in the challenge mice. Taken together, our study demonstrates that highly conserved M2e and FP epitope of HA of H5N1 and H7N9 influenza viruses can be used as important targets for development of safe and economical universal influenza vaccines, and that the position of H7N9 M2e and H5N1 HA epitope sequences in the vaccine components had no significant effects on the immunogenicity and efficacy of M2e-FP-based subunit vaccines.
Copyright ? 2017 Institut Pasteur. Published by Elsevier Masson SAS. All rights reserved.
[h=4]KEYWORDS:[/h] Influenza virus; M2e; hemagglutinin fusion peptide; protection; universal vaccines
PMID: 28903071 DOI: 10.1016/j.micinf.2017.08.010